全球住院治療相關的聯盟條件、契約(2014年∼2020年)

本報告提供全球住院治療市場上企業聯盟契約的締結趨勢與其內容相關分析，近幾年的聯盟契約/交易的形成情形與特徵，平均交易條件，代表性契約的概要，大醫藥品企業趨勢，近幾年的聯盟交易一覽與其明細的資訊。

目錄

摘要整理

第1章 簡介

第2章 住院治療交易趨勢

• 簡介
• 多年來的聯盟住院治療
• 各交易類型的住院治療聯盟
• 各產業部門的住院治療聯盟
• 各開發階段的住院治療聯盟
• 各技術類型的住院治療聯盟
• 各治療適應症住院治療聯盟

第3章 住院治療相關的聯盟的金錢條件

• 簡介
• 披露醫院照護聯盟關係的財務條件
• 住院治療聯盟標題價值
• 住院治療交易的預付款
• 住院治療契約的里程金
• 住院治療費用率

第4章 主要住院治療交易和交易對象

• 簡介
• 住院治療的聯盟最活躍
• 住院治療中最積極的交易製造商清單
• 各價值前幾名的住院治療交易

第5章 醫院治療契約文件名錄

• 簡介
• 契約文件可利用的住院治療聯盟契約

第6章 各治療標的住院治療交易

• 簡介
• 醫院照護的各治療目標的交易

附錄

‘Global Hospital Care Partnering 2014-2020: Deal trends, players and financials’ provides comprehensive understanding and unprecedented access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies.

‘Global Hospital Care Partnering 2014 to 2020’ provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

• Trends in Hospital Care partnering deals

• Financial deal terms for headline, upfront and royalty by stage of development

• Hospital Care partnering agreement structure

• Hospital Care partnering contract documents

• Top Hospital Care deals by value

• Most active Hospital Care dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.

The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Hospital Care dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Hospital Care dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Hospital Care deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Hospital Care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Hospital Care deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Hospital Care partnering deals by specific Hospital Care target announced since 2014. The chapter is organized by specific Hospital Care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Hospital Care partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.

Report scope

‘Global Hospital Care Partnering 2014 to 2020’ is intended to provide the reader with an in-depth understanding and access to Hospital Care trends and structure of deals entered into by leading companies worldwide.

‘Global Hospital Care Partnering 2014 to 2020’ includes:

• Trends in Hospital Care dealmaking in the biopharma industry since 2014
• Analysis of Hospital Care deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Hospital Care deal contract documents
• Comprehensive access to over 950 Hospital Care deal records
• The leading Hospital Care deals by value since 2014
• Most active Hospital Care dealmakers since 2014

The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other hospital care indications.

In ‘Global Hospital Care Partnering 2014 to 2020’, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

‘The Global Hospital care Partnering 2014-2020 report’ provides comprehensive access to available deals and contract documents for over 950 hospital care deals. Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?

• What is actually granted by the agreement to the partner company?

• What exclusivity is granted?

• What is the payment structure for the deal?

• How are the sales and payments audited?

• What is the deal term?

• How are the key terms of the agreement defined?

• How are IPRs handled and owned?

• Who is responsible for commercialization?

• Who is responsible for development, supply, and manufacture?

• How is confidentiality and publication managed?

• How are disputes to be resolved?

• Under what conditions can the deal be terminated?

• What happens when there is a change of ownership?

• What sublicensing and subcontracting provisions have been agreed?

• Which boilerplate clauses does the company insist upon?

• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

• Which jurisdiction does the company insist upon for agreement law?

Benefits

‘Global Hospital Care Partnering 2014 to 2020’ provides the reader with the following key benefits:

• In-depth understanding of Hospital Care deal trends since 2014

• Access Hospital Care deal headline, upfront, milestone and royalty data

• Research hundreds of actual contracts between Hospital Care partner companies

• Comprehensive access to over 950 links to actual Hospital Care deals entered into by the world's biopharma companies

• Indepth review of Hospital Care deals entered into by the top 25 most active dealmakers

• Benchmark the key deal terms companies have agreed in previous deals

• Identify key terms under which companies partner Hospital Care opportunities

• Uncover companies actively partnering Hospital Care opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Hospital Care dealmaking

• 2.1. Introduction
• 2.2. Hospital Care partnering over the years
• 2.3. Hospital Care partnering by deal type
• 2.4. Hospital Care partnering by industry sector
• 2.5. Hospital Care partnering by stage of development
• 2.6. Hospital Care partnering by technology type
• 2.7. Hospital Care partnering by therapeutic indication

Chapter 3 -Financial deal terms for Hospital Care partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for Hospital Care partnering
• 3.3. Hospital Care partnering headline values
• 3.4. Hospital Care deal upfront payments
• 3.5. Hospital Care deal milestone payments
• 3.6. Hospital Care royalty rates

Chapter 4 - Leading Hospital Care deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in Hospital Care partnering
• 4.3. List of most active dealmakers in Hospital Care
• 4.4. Top Hospital Care deals by value

Chapter 5 - Hospital Care contract document directory

• 5.1. Introduction
• 5.2. Hospital Care partnering deals where contract document available

Chapter 6 - Hospital Care dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by Hospital Care therapeutic target

Appendices

• Appendix 1 - Directory of Hospital Care deals by company A-Z 2014 to 2020
• Appendix 2 - Directory of Hospital Care deals by deal type 2014 to 2020
• Appendix 3 - Directory of Hospital Care deals by stage of development 2014 to 2020
• Appendix 4 - Directory of Hospital Care deals by technology type 2014 to 2020
• Further reading on dealmaking
• Deal type definitions
• About Wildwood Ventures
• Current Partnering
• Current Agreements
• Recent report titles from CurrentPartnering

Table of figures

• Figure 1: Hospital Care partnering since 2014
• Figure 2: Hospital Care partnering by deal type since 2014
• Figure 3: Hospital Care partnering by industry sector since 2014
• Figure 4: Hospital Care partnering by stage of development since 2014
• Figure 5: Hospital Care partnering by technology type since 2014
• Figure 6: Hospital Care partnering by indication since 2014
• Figure 7: Hospital Care deals with a headline value
• Figure 8: Hospital Care deals with upfront payment values
• Figure 9: Hospital Care deals with milestone payment
• Figure 10: Hospital Care deals with royalty rates
• Figure 11: Active Hospital Care dealmaking activity- 2014 to 2020
• Figure 12: Top Hospital Care deals by value since 2014